ReviewDrugs2018
Current and Future Treatment Options for Myelodysplastic Syndromes: More Than Hypomethylating Agents and Lenalidomide?
Katja Sockel et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it
ReviewDrugs2018
Katja Sockel et al.PubMed ↗Publisher ↗
No numbers read from the abstract.